Phase 4, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to evaluate the effect of SPN-538 for the prophylaxis of migraine in pediatric patients 6 to 11 years old.
6 years old - 11 years old
Compensation for time and travel up to
Transportation can be arranged at no cost to you
Study related exams at to cost
TOPAZ Clinical Research 2513 E. Semoran Blvd Apopka, FL 32703